BioHealth News Archive

BioMarker Strategies Awarded Phase II National Cancer Institute Contract to Develop Novel Predictive Test for Response to Immunotherapies for Patients with Non-Small Cell Lung Cancer

BioMarker Strategies Awarded Phase II National Cancer Institute Contract to Develop Novel Predictive Test for Response to Immunotherapies for Patients with Non-Small Cell Lung Cancer

BioMarker Strategies, LLC, today announced that the National Cancer Institute (NCI) has awarded the Company a Phase II Small Business Innovation Research (SBIR) contract…

Read More
Adaptive Phage gets $10M from DoD for antibacterial phage therapies – MedCity News

Adaptive Phage gets $10M from DoD for antibacterial phage therapies – MedCity News

A company developing treatments for drug-resistant bacterial infections is getting a boost from the Department of Defense. Gaithersburg, Maryland-based Adaptive Phage Therapeutics, also known…

Read More
Digital Health Expert Robert Lord Joins LionBird as New Partner

Digital Health Expert Robert Lord Joins LionBird as New Partner

CHICAGO/TEL AVIV-YAFO (January 7, 2020) – LionBird has a new partner: Robert Lord. Lord is the co-founder of Protenus, a healthcare compliance analytics company…

Read More
Top Life Sciences Startups to Watch in 2020 | BioSpace

Top Life Sciences Startups to Watch in 2020 | BioSpace

BioSpace is proud to present its NextGen Bio “Class of 2020,” a list of up-and-coming life sciences companies in North America that launched* no earlier than…

Read More

3 Pillars for Success in the Next Decade of Life Science Startups | LinkedIn

Here we are… 2020. As we approach this new decade with a fresh lens of excitement and rejuvenated ambition for impact, there are a…

Read More
Analysts weigh in on what to expect in biopharma this year – MedCity News

Analysts weigh in on what to expect in biopharma this year – MedCity News

Oncology, neurology, and fatty liver disease are among the areas where one can expect to see significant activity this year, according to forecasts from…

Read More
Seeking Pediatric Device Innovators; Contest Opens for $250K and Accelerator Support | HealthLeaders Media

Seeking Pediatric Device Innovators; Contest Opens for $250K and Accelerator Support | HealthLeaders Media

Competition for startups aims to increase the pace of development and commercialization of critically needed pediatric medical devices. In the world of innovation, devices…

Read More
Chesapeake Digital Health Exchange aims to spur regional startup growth – Technical.ly Baltimore

Chesapeake Digital Health Exchange aims to spur regional startup growth – Technical.ly Baltimore

A new initiative spearheaded by Johns Hopkins is setting out to organize and grow the digital health community in the region, with an aim…

Read More
TEDCO’s Maryland Innovation Initiative Infuses $2.63M in New Round of Projects

TEDCO’s Maryland Innovation Initiative Infuses $2.63M in New Round of Projects

COLUMBIA, Md., Jan. 8, 2020 /PRNewswire/ -- TEDCO, Maryland's economic engine for technology companies, announced its recent round of funding for select projects through the…

Read More
CIT GAP Funds Invests in Jeeva to Decentralize and Improve Clinical Trial Operations

CIT GAP Funds Invests in Jeeva to Decentralize and Improve Clinical Trial Operations

The Center for Innovative Technology (CIT) today announced that CIT GAP Funds has invested in Herndon, Va.-based Jeeva Informatics Solutions Inc. (Jeeva), a precision…

Read More
NexImmune Appoints Industry Veteran Chief Medical Officer to Executive Team · BioBuzz

NexImmune Appoints Industry Veteran Chief Medical Officer to Executive Team · BioBuzz

NexImmune, a clinical-stage biopharmaceutical company developing novel immune-therapeutics based on a proprietary Artificial Immune Modulation (AIM) nanotechnology platform, announced that industry veterans Han Myint,…

Read More
NexImmune Bolsters Leadership Team Adding Former MedImmune Executive as Chief Financial Officer · BioBuzz

NexImmune Bolsters Leadership Team Adding Former MedImmune Executive as Chief Financial Officer · BioBuzz

NexImmune, a clinical-stage biopharmaceutical company developing novel immune-therapeutics based on a proprietary Artificial Immune Modulation (AIM) nanotechnology platform, announced that industry veteran John Trainer,…

Read More
LumaCyte Awarded Frost & Sullivan 2019 Global Single-Cell Analysis New Product Innovation Award for Its Novel Laser Force Cytology™ Technology

LumaCyte Awarded Frost & Sullivan 2019 Global Single-Cell Analysis New Product Innovation Award for Its Novel Laser Force Cytology™ Technology

SANTA CLARA, Calif., Jan. 7, 2020 /PRNewswire/ -- Based on its recent analysis of the global single-cell analysis market, Frost & Sullivan recognizes LumaCyte, LLC…

Read More
NexImmune Expands Executive Team with Appointments of Chief Medical Officer and Chief Financial Officer

NexImmune Expands Executive Team with Appointments of Chief Medical Officer and Chief Financial Officer

GAITHERSBURG, Md., Jan. 09, 2020 (GLOBE NEWSWIRE) -- NexImmune, a clinical-stage biopharmaceutical company developing novel immune-therapeutics based on a proprietary Artificial Immune Modulation (AIM)…

Read More
Laboratory Space Available

Laboratory Space Available

Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® REIT, is the first and longest-tenured owner, operator, and developer uniquely focused on collaborative life…

Read More